14th Annual Missouri Baptist STEMI Symposium: From Door to Discharge: Elevating the Patient Journey

Friday, March 6, 2026, 7:00 AM - 3:10 PM, The Doubletree Hotel, Chesterfield, MO


AMA PRA Category 1 Credits™ (7.00 hours), ABIM MOC Part II (7.00 hours), ABS CC (7.00 hours), ACPE Contact Hours (7.00 hours), AMA PRA Category 1 Credit™ Designated Non-Physician Participation Certification (7.00 hours), ANCC Contact Hours (7.00 hours), IPCE Credits (7.00 hours)

The 14th Annual Missouri Baptist STEMI Symposium: From Door to Discharge: Elevating the Patient Journey is planned and implemented interprofessionally by physicians, nurses, pharmacists, and EMS . This activity is designed for specialties and professions in the target audience but may be of interest to specialties invited to attend, but not on the planning committee. This 6.5-hour live activity will provide education through lectures, case presentations, panel discussions, and question & answer sessions. The activity will highlight best practices across emergency and cardiology. The goal of this activity is to enhance knowledge, skills, strategy, performance, and patient care.

1. Discuss evolving strategies and technologies for the treatment of ST elevation myocardial infarction
2. Discuss issues causing patients with STEMI to delay seeking medical care
3. Discuss EKG findings in STEMI, including misses, STEMI mimics, and use of artificial intelligence for EKG interpretation
4. Discuss the management of cardiogenic shock in the cath lab, including basics of hemodynamic support with axial flow pumps and ECMO
5. Discuss hemodynamic support in the CCU update on pharmacology and management of hemodynamic support devices
6. Review new ACCAHA guidelines for management of acute coronary syndromes
7. Discuss the critical importance of cardiac rehab and improving participation with the cardiac rehab navigator program

Heart Center Symposium Registration 

In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Medical Association (AMA)
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

The cancellation cut-off dates and fees are specific to each course. Refer to the cancellation policy on the individual course page. Please send cancellation requests to [email protected].

WashU Medicine CME reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred, such as non-refundable airline tickets or hotel penalties.

Accessibility Statement

Continuing Medical Education at Washington University School of Medicine fully complies with the legal requirements of the Americans with Disabilities Act rules and regulations thereof. If any participant of this meeting is in need of accommodations, please do not hesitate to submit written requests, at least one month prior to seminar date.

Washington University School of Medicine in St. Louis School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Washington University School of Medicine in St. Louis adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, March 6, 2026